Peripheral Arterial Disease Trial, Recruiting (NCT06308562)

Peripheral Arterial Disease Trial, Recruiting NCT06308562 Sponsor: Mayo Clinic Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06308562 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years of age
Both men and women are eligible
People who are expected to have a below-the-knee (transtibial) amputation
People who have peripheral arterial disease (a condition affecting blood flow in the arteries), and who may have had a specific oxygen level test on the skin (called TcPO2) if this was carried out
People who are able to give their own consent to participate, or who have a representative who can give consent on their behalf

Who may not be able to join:

People who have a known allergy to any of the materials used in the compression device being studied
People who have a terminal illness or who are currently receiving chemotherapy for cancer
People who are unable to receive ongoing care in Rochester
People who have difficulty following instructions or monitoring their own residual limb (the remaining part of the leg after amputation)
People who are considered part of a vulnerable study population (confirm with trial site)
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew Melin, M.D., Mayo Clinic

Phone: (507) 538-7425

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06308562

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: (507) 538-7425

More information: https://clinicaltrials.gov/study/NCT06308562

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years of age
Both men and women are eligible
People who are expected to have a below-the-knee (transtibial) amputation
People who have peripheral arterial disease (a condition affecting blood flow in the arteries), and who may have had a specific oxygen level test on the skin (called TcPO2) if this was carried out
People who are able to give their own consent to participate, or who have a representative who can give consent on their behalf

Who may not be able to join:

People who have a known allergy to any of the materials used in the compression device being studied
People who have a terminal illness or who are currently receiving chemotherapy for cancer
People who are unable to receive ongoing care in Rochester
People who have difficulty following instructions or monitoring their own residual limb (the remaining part of the leg after amputation)
People who are considered part of a vulnerable study population (confirm with trial site)
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

7 July 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Surgical site infection; Wound dehiscence; Pain control; Time to prosthetic fitting

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov